Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes

Growth Factors

Volumn 28, Issue 2, 2010, Pages 82-97

  Chen, Chun Liang ^a   Mehta, Veela B ^a   Zhang, Hong Yi ^a   Wu, Dana ^a   Otabor, Iyore ^a   Radulescu, Andrei ^a   El Assal, Osama N ^a   Feng, Jiexiong ^a   Chen, Yan ^a   Besner, Gail E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

HB EGF; Injury; Intestine; Transgenic; Villin promoter; Villous

Indexed keywords

HEPARIN BINDING EPIDERMAL GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; COLON; CONTROLLED STUDY; DUODENUM; FEMALE; GENE OVEREXPRESSION; HYPERPLASIA; INTESTINE CELL; INTESTINE CRYPT; INTESTINE HYPERPLASIA; INTESTINE INJURY; INTESTINE VILLUS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTECTION; TRANSGENE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; ENTEROCYTES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINES; MALE; MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; PHENOTYPE; PROMOTER REGIONS, GENETIC; TRANSGENES; UP-REGULATION;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 77949435377     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903407365     Document Type: Article

References (51)

1. Ahuja V, Dieckgraefe BK, Anant S. 2006. Molecular biology of the small intestine. Curr Opin Gastroenterol 22:90-94.
2. Besner GE, Klagsbrun M. 1991. Macrophages secrete a heparinbinding inhibitor of endothelial cell growth. Microvasc Res 42: 187-197.
3. Chen C-L, Loy A, Cen L, Chan C, Hsieh F-C, Cheng G, Wu B, Qualman SJ, Kunisada K, Yamauchi-Takihara K, et al. 2007. Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells. BMC Cancer 7:111.
4. Davis KM, Brigstock DR, Johnson PR, Crissman-Combs MA, McCarthy DW, Downing MT, Besner GE. 1996. Production of glycosylated heparin-binding EGF-like growth factor in HeLa cells using vaccinia virus. Protein Expr Purif 8:57-67.
5. Deitch EA, Xu DZ, Qi L. 1990. Different lymphocyte compartments respond differently to mitogenic stimulation after thermal injury. Ann Surg 211:72-77.
6. El-Assal ON, Besner GE. 2004. Heparin-binding epidermal growth factor-like growth factor and intestinal ischemia-reperfusion injury. Semin Pediatr Surg 13:2-10.
7. El-Assal ON, Besner GE. 2005. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology 129:609-625.
8. El-Assal ON, Radulescu A, Besner GE. 2007. Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation. Surgery 142:234-242.
9. Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. 1997. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 16:1268-1278.
10. Feng J, Besner GE. 2007. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg 42:214-220.
11. Feng J, El-Assal ON, Besner GE. 2005. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis. Semin Pediatr Surg 14:167-174.
12. Feng J, El-Assal ON, Besner GE. 2006. Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. J Pediatr Surg 41: 742-747; discussion 742-747.
13. Freeman H-J. 2008. Crypt region localization of intestinal stem cells in adults. World J Gastroenterol 14:7160-7162.
14. Gordon JI, Hermiston ML. 1994. Differentiation and self-renewal in the mouse gastrointestinal epithelium. Curr Opin Cell Biol 6: 795-803.
15. Haegebarth A, Clevers H. 2009. Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol 174:715-721.
16. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. 1991. A heparin-binding growth factor secreted by macrophagelike cells that is related to EGF. Science 251:936-939.
17. Iwamoto R, Mekada E. 2000. Heparin-binding EGF-like growth factor: A juxtacrine growth factor. Cytokine Growth Factor Rev 11:335-344.
18. Iwamoto R, Handa K, Mekada E. 1999. Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J Biol Chem 274: 25906-25912.
19. Jin K, Mao XO, Del Rio Guerra G, Jin L, Greenberg DA. 2005. Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 30-kinase and mitogen-activated protein kinase. J Neurosci Res 81:497-505.
20. Khai NC, Takahashi T, Ushikoshi H, Nagano S, Yuge K, Esaki M, Kawai T, Goto K, Murofushi Y, Fujiwara T, et al. 2006. In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: A comparative study to HGF. J Hepatol 44:1046-1054.
21. Kiso S, Kawata S, Tamura S, Higashiyama S, Ito N, Tsushima H, Taniguchi N, Matsuzawa Y. 1995. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Hepatology 22:1584-1590.
22. Kiso S, Kawata S, Tamura S, Inui Y, Yoshida Y, Sawai Y, Umeki S, Ito N, Yamada A, Miyagawa J-I, et al. 2003. Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology 124:701-707.
23. Krampera M, Pasini A, Rigo A, Scupoli MT, Tecchio C, Malpeli G, Scarpa A, Dazzi F, Pizzolo G, Vinante F. 2005. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: Inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106:59-66.
24. Liaudet L, Soriano F, Szabó E, Virág L,Mabley J, Salzman A, Szabo C. 2000. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci USA 97:10203-10208.
25. Lin J, Hutchinson L, Gaston SM, Raab G, Freeman MR. 2001. BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: A unique role for proHB-EGF in cell survival regulation. J Biol Chem 276: 30127-30132.
26. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
27. Madison BB, Dunbar L, Qiao XT, Braunstein K, Braunstein E, Gumucio DL. 2002. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J Biol Chem 277:33275-33283.
28. May R, Riehl TE, Hunt C, Sureban SM, Anant S, Houchen CW. 2008. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinaselike-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 26:630-637.
29. Mehta VB, Besner GE. 2007. HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors 25:253-263.
30. Mishima K, Higashiyama S, Nagashima Y, Miyagi Y, Tamura A, Kawahara N, Taniguchi N, Asai A, Kuchino Y, Kirino T. 1996. Regional distribution of heparin-binding epidermal growth factor-like growth factor mRNA and protein in adult rat forebrain. Neurosci Lett 213:153-156.
31. Mishra R, Leahy P, Simonson MS. 2002. Gene expression profiling reveals role for EGF-family ligands in mesangial cell proliferation. Am J Physiol Renal Physiol 283:F1151-F1159.
32. Mori S, Tanaka M, Nanba D, Nishiwaki E, Ishiguro H, Higashiyama S, Matsuura N. 2003. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J Biol Chem 278:46029-46034.
33. Nanba D, Mammoto A, Hashimoto K, Higashiyama S. 2003. Proteolytic release of the carboxy-terminal fragment of proHBEGF causes nuclear export of PLZF. J Cell Biol 163:489-502.
34. Nicholson RI, Gee JM, Harper ME. 2001. EGFR and cancer prognosis. Eur J Cancer 37:S9-15.
35. Nishi E, Prat A, Hospital V, Elenius K, Klagsbrun M. 2001. N-arginine dibasic convertase is a specific receptor for heparinbinding EGF-like growth factor that mediates cell migration. EMBO J 20:3342-3350.
36. Pan B, Sengoku K, Goishi K, Takuma N, Yamashita T, Wada K, Ishikawa M. 2002. The soluble and membrane-anchored forms of heparin-binding epidermal growth factor-like growth factor appear to play opposing roles in the survival and apoptosis of human luteinized granulosa cells.Mol Hum Reprod 8:734-741.
37. Perrella MA,Maki T, Prasad S, Pimental D, Singh K, Takahashi N, Yoshizumi M, Alali A, Higashiyama S, Kelly RA. 1994. Regulation of heparin-binding epidermal growth factor-like growth factor mRNA levels by hypertrophic stimuli in neonatal and adult rat cardiac myocytes. J Biol Chem 269:27045-27050.
38. Raab G, Klagsbrun M. 1997. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333:F179-F199.
39. Rocks N, Estrella C, Paulissen G, Quesada-Calvo F, Gilles C, Gueders MM, Crahay C, Foidart JM, Gosset P, Noel A, et al. 2008. The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis. Cell Prolif 41: 988-1001.
40. Rocourt DV, Mehta VB, Besner GE. 2007. Heparin-binding EGFlike growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury. J Surg Res 139: 269-273.
41. Schenk M, Mueller C. 2008. The mucosal immune system at the gastrointestinal barrier. Best Pract Res Clin Gastroenterol 22: 391-409.
42. Scoville DH, Sato T, He XC, Li L. 2008. Current view: Intestinal stem cells and signaling. Gastroenterology 134:849-864.
43. Singh AB, Sugimoto K, Harris RC. 2007. Juxtacrine activation of epidermal growth factor (EGF) receptor by membraneanchored heparin-binding EGF-like growth factor protects epithelial cells from anoikis while maintaining an epithelial phenotype. J Biol Chem 282:32890-32901.
44. Sugiura S, Kitagawa K, Tanaka S, Todo K, Omura-Matsuoka E, Sasaki T, Mabuchi T, Matsushita K, Yagita Y, Hori M. 2005. Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats. Stroke 36: 859-864.
45. Thompson SA, Higashiyama S, Wood K, Pollitt NS, Damm D, McEnroe G, Garrick B, Ashton N, Lau K, Hancock N. 1994. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. J Biol Chem 269:2541-2549.
46. Uetani T, Nakayama H, Okayama H, Okura T, Higaki J, Inoue H, Higashiyama S. 2009. Insufficiency of pro-heparin-binding epidermal growth factor-like growth factor shedding enhances hypoxic cell death in H9c2 cardiomyoblasts via the activation of caspase-3 and c-Jun N-terminal kinase. J Biol Chem 284: 12399-12409.
47. Wang Y, Li J, Ying Wang C. Yan Kwok AH, Leung FC. 2007. Epidermal growth factor (EGF) receptor ligands in the chicken ovary: I. Evidence for heparin-binding EGF-like growth factor (HB-EGF) as a potential oocyte-derived signal to control granulosa cell proliferation and HB-EGF and kit ligand expression. Endocrinology 148:3426-3440.
48. Xia G, Martin AE, Michalsky MP, Besner GE. 2002. Heparinbinding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/ reperfusion injury. J Pediatr Surg 37:1081-1087.
49. Xia G, Martin AE, Besner GE. 2003. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/ reperfusion injury. J Pediatr Surg 38:434-439.
50. Zhuang S, Kinsey GR, Rasbach K, Schnellmann RG. 2008. Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells. Am J Physiol Renal Physiol 294:F459-F468.
51. Zushi S, Shinomura Y, Kiyohara T, Miyazaki Y, Tsutsui S, Sugimachi M, Higashimoto Y, Kanayama S, Matsuzawa Y. 1997. Role of heparin-binding EGF-related peptides in proliferation and apoptosis of activated ras-stimulated intestinal epithelial cells. Int J Cancer 73:917-923.